AARD EBITDA Growth
Aardvark Therapeutics Inc · EBITDA Growth
AARD EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-90.77%period ending
AARD TTM EBITDA YoY % (-212.94% → -90.77%)
Year-over-year change
High-resolution chart · PNG
AARD ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| -90.7658% | |
| -147.0091% | |
| -172.2564% | |
| -238.5609% | |
| -212.9402% |